Particle Therapy Market: Exploring New Trends and Price Dynamics with country level Analysis
Ngày đăng: 11-10-2023 |
Ngày cập nhật: 11-10-2023
According to the new market research report "Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) - Global Forecast to 2027", published by MarketsandMarkets™, the global market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137
The particle therapy market is analyzed at the country level, considering various factors such as therapy type, component type, system, cancer type, and application. The countries covered in the market report include:
North America: U.S., Canada, Mexico
Europe: Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe
Asia-Pacific: China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific
Middle East and Africa: Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa
South America: Brazil, Argentina, Rest of South America
North America dominates the particle therapy market due to several factors such as the increasing adoption of particle therapy in clinical trials, a rising number of particle therapy centers worldwide, the growing occurrence of cancer, increasing investments in cancer research, and the establishment of more particle therapy centers and clinical trials in the region.
Europe and Asia-Pacific are expected to experience significant growth in the particle therapy market. These regions are witnessing improvements in per capita income, healthcare infrastructure, and supportive government activities. Countries such as China, Japan, and India are driving the growth in these regions.
The country-specific analysis in the particle therapy market report includes the identification of market impacting factors and changes in regulations within each country. Factors such as consumption volumes, production sites and volumes, import-export analysis, price trend analysis, cost of raw materials, and downstream and upstream value chain analysis are considered to forecast the market scenario for individual countries.
Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=12809137
Price dynamics in the particle therapy market may vary depending on factors such as the type of particle therapy system, components, and geographical location. Market competition, technological advancements, and cost factors associated with system installation, maintenance, and operation can influence pricing strategies.
Key Market Players:
Prominent players in the particle therapy market include IBA Worldwide (EU), Mevion Medical Systems (US), Varian Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Hitachi, Ltd. (Japan), Toshiba Medical Systems Corporation (Japan), and Provision Healthcare, LLC (US). These players have implemented various development strategies such as product launches, acquisition, and expansion to other geography.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=12809137
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137
The particle therapy market is analyzed at the country level, considering various factors such as therapy type, component type, system, cancer type, and application. The countries covered in the market report include:
North America: U.S., Canada, Mexico
Europe: Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe
Asia-Pacific: China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific
Middle East and Africa: Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa
South America: Brazil, Argentina, Rest of South America
North America dominates the particle therapy market due to several factors such as the increasing adoption of particle therapy in clinical trials, a rising number of particle therapy centers worldwide, the growing occurrence of cancer, increasing investments in cancer research, and the establishment of more particle therapy centers and clinical trials in the region.
Europe and Asia-Pacific are expected to experience significant growth in the particle therapy market. These regions are witnessing improvements in per capita income, healthcare infrastructure, and supportive government activities. Countries such as China, Japan, and India are driving the growth in these regions.
The country-specific analysis in the particle therapy market report includes the identification of market impacting factors and changes in regulations within each country. Factors such as consumption volumes, production sites and volumes, import-export analysis, price trend analysis, cost of raw materials, and downstream and upstream value chain analysis are considered to forecast the market scenario for individual countries.
Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=12809137
Price dynamics in the particle therapy market may vary depending on factors such as the type of particle therapy system, components, and geographical location. Market competition, technological advancements, and cost factors associated with system installation, maintenance, and operation can influence pricing strategies.
Key Market Players:
Prominent players in the particle therapy market include IBA Worldwide (EU), Mevion Medical Systems (US), Varian Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Hitachi, Ltd. (Japan), Toshiba Medical Systems Corporation (Japan), and Provision Healthcare, LLC (US). These players have implemented various development strategies such as product launches, acquisition, and expansion to other geography.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=12809137
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
